Department of Hematology, Aerospace Center Hospital, Beijing, China.
HLA. 2021 Sep;98(3):207-212. doi: 10.1111/tan.14372. Epub 2021 Jul 26.
Leukemia is a complex disease in which mutations and other genomic and epigenomic abnormalities play a role in both its initiation and progression. Acute lymphoid leukemia (ALL) patients with loss of heterozygosity (LOH) in the HLA region before transplantation have been described rarely. In this report, we described two ALL cases with LOH encompassing the HLA, wholly or partly. HLA molecular typing was performed on peripheral blood (PB) and somatic cell. Simultaneously, we performed whole-exome sequencing. Typing results on PB samples collected during blast crisis demonstrated complete or partial homozygosity at the -A, -B, -C, -DR, and -DQ loci. Two somatic samples demonstrated heterozygosity at all loci. LOH at the HLA gene locus may significantly influence the donor search, resulting in misidentification of homozygous donors. We recommend confirming the patients' HLA typing with hematological malignancies when homozygosity is detected at any locus by using somatic samples or alternatively from PB when remission is achieved.
白血病是一种复杂的疾病,突变和其他基因组和表观基因组异常在其发生和进展中都发挥作用。在移植前 HLA 区域杂合性丢失(LOH)的急性淋巴细胞白血病(ALL)患者很少见。在本报告中,我们描述了两例完全或部分包含 HLA 的 ALL 病例存在 LOH。对外周血(PB)和体细胞进行 HLA 分子分型。同时,我们进行了全外显子组测序。在爆发性危机期间采集的 PB 样本的分型结果表明在-A、-B、-C、-DR 和-DQ 位点完全或部分纯合。两个体细胞样本在所有位点均显示杂合性。HLA 基因座的 LOH 可能会显著影响供体搜索,导致纯合供体的错误识别。当通过体细胞样本或在缓解时通过 PB 检测到任何位点的纯合性时,我们建议在存在血液恶性肿瘤时确认患者的 HLA 分型。